,
,
,
,
Choix des outils d'évaluation de la fibrose ,
du score METAVIR pour classer les patients dans le groupe cirrhose ,
,
,
,
,
, C. Les outils d'évaluation de l'atteinte hépatique
,
,
,
,
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, Eurosurveillance, vol.13, pp.4-6, 2004. ,
Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases, a systematic review and metaanalysis, Intern J Inf Dis, vol.14, pp.1024-1055, 2010. ,
Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB, 2008. ,
, J Hepatol, vol.53, pp.1006-1012, 2010.
Histoire naturelle de l'hépatite B, Rev Virologie, vol.14, pp.5-11, 2010. ,
Hépatites delta virus, The Lancet, vol.378, pp.73-85, 2011. ,
A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma, Gastroenterology, vol.136, issue.5, pp.1629-1667, 2009. ,
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men, Hepatology, vol.29, issue.4, pp.1306-1316, 1999. ,
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS), The Lancet, vol.360, pp.1921-1927, 2002. ,
Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study, Liver Int, 2015. ,
Hepatitis B and human immunodeficiency virus co-infection, World J Gastroenterol, vol.20, issue.46, p.17360, 2014. ,
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort, AIDS, vol.19, issue.6, pp.593-601, 2005. ,
Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey: Liver-related causes of death in HIV-infected patients in France, HIV Med, vol.16, issue.4, pp.230-239, 1995. ,
Hépatitis delta in HIV-infected individuals in Europe, AIDS, vol.25, pp.1987-1992, 2011. ,
Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus, J Viral Hepat, vol.17, pp.65-76, 2010. ,
, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, 2015.
Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Ministère des Affaires sociales et de la santé, Prise en charge médicale des personnes vivant avec le VIH : Actualisation 2014 du rapport 2013: recommandations du groupe d'experts. La documentation française, 2014. ,
Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?, Antivir Ther, vol.13, issue.1, pp.97-102, 2008. ,
Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France, Liver Int, vol.35, pp.65-70, 2015. ,
,
, Gastroenterol Clin Biol, vol.26, pp.9-22, 2002.
Hepatitis C: the clinical spectrum of the disease, J Hepatol, vol.31, pp.9-16, 1999. ,
Use of first generation hcv protease inhibitors in patients coinfected by HIV and HCV genotype 1, Liver Int, vol.34, pp.869-89, 2014. ,
Prévalence de la fibrose hépatique F3/F4 au sein de la cohorte ANRS C013-HEPAVIH, Médecine et maladies infectieuses, vol.38, p.110, 2008. ,
, AFEF, recommandations AFEF pour l'élimination de l'infection par le virus de l'hépatite C en France, 2018.
Advances in the management of HIV/HCV coinfection, Hepatol Int, vol.10, pp.424-435, 2016. ,
Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients, AIDS, vol.29, issue.14, pp.1821-1830, 2015. ,
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV, AIDS, vol.20, pp.419-427, 2006. ,
Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections, J Viral Hepat, vol.7, pp.15-22, 2000. ,
Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in, AIDS, vol.19, pp.1361-1365, 2005. ,
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents, Clin Gastroenterol Hepatol, vol.15, pp.132-136, 2017. ,
Liver disease as a major cause of death in HIVinfected patients: role of hepatitis C and B viruses and alcohol, J Hepatol, vol.42, pp.799-805, 2005. ,
Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus, AIDS, vol.21, issue.18, pp.2546-2555, 2007. ,
HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms, Clin Infect Dis, vol.38, pp.65-72, 2004. ,
Antiretroviral drugs and liver injury, AIDS, vol.22, issue.1, pp.1-13, 2008. ,
Assessment of mitochondrial toxicity in human cells treated with Ténofovir: comparison with other nucleoside reverse transcriptase inhibitors ,
, Antimicrob Agents Chemother, vol.46, issue.3, pp.716-739, 2002.
Hepatic steatosis B virus infected patients: metaanalysis of risk factors and comparison with hepatitis C infected patients, J Gastroenterol Hepatol, vol.26, pp.1361-1367, 2011. ,
Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV ,
, Agence Nationale pour la Recherche contre le SIDA et les hepatites virales CO3 Aquitaine Cohort, J Acquir Immune Defic Syndr, vol.45, pp.168-173, 2007.
An algorithm for the grading of activity in chronic hepatitis C.The METAVIR Cooperative Study Group, Hepatology, vol.24, pp.289-293, 1996. ,
Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF), Hepatology, vol.32, pp.477-481, 2000. ,
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C, Gastroenterology, vol.128, pp.343-350, 2005. ,
Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers, J Viral Hepat, vol.17, pp.280-286, 2010. ,
Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients, J Acquir Immune Defic Syndr, vol.41, pp.175-179, 2006. ,
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients, J Viral Hepat, vol.18, pp.61-69, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00851726
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis, J Viral Hepat, vol.19, issue.2, pp.212-221, 2012. ,
Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®, J Hepatol, vol.61, issue.3, pp.550-557, 2014. ,
Comparison of noninvasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study-ANRS HC02, J Hepatol, vol.48, pp.765-773, 2008. ,
Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients, J Hepatol, vol.50, pp.1074-1083, 2009. ,
Development of a simple noninvasive index to predict significant fibrosis patients with HIV/HCV co-infection, Hepatology, vol.43, pp.1317-1325, 2006. ,
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model, Hepatology, vol.36, pp.986-92, 2002. ,
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C, Hepatology, vol.38, issue.2, pp.518-544, 2003. ,